BSFA.L
Get informed when a big investor buys or sells
+ FollowOvervalued by 108.4% based on the discounted cash flow analysis.
| Market cap | $141.21 Million |
|---|---|
| Enterprise Value | $141.63 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 3.63 |
| Outstanding Shares | 128,374,437 |
| P/E Ratio | -1.11 |
|---|---|
| PEG | -5.29 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1884.68 |
| Enterprise Value to EBIT | -44.93 |
| Enterprise Value to Net Income | -50 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.27 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal ac...